Press Release
California
Mass Transit Ridership is Falling in Southern California, Study Finds
By Kenneth Artz A new study finds commuters are increasingly choosing to use cars over mass transit in Southern California. Mass transit use in six southern California counties declined significantly during the past decade, according to a new study by researchers at the University of California at Los Angeles (UCLA) ...
Pacific Research Institute
March 23, 2018
Business & Economics
Small Business Taxes: What to Expect in 2018
By Matt D’Angelo The recent tax legislation mean small businesses everywhere are getting a break on their taxes. The legislation, which is one of the most significant tax overhauls passed in decades, provides pass-through businesses and corporate entities with lower rates. Insureon, an insurance company that works with small businesses, ...
Pacific Research Institute
March 21, 2018
Business & Economics
Joel Fox on PRI’s California Business Climate Survey
Survey: Biz Execs Down on CA A survey of business executives in highly sought after industries such as clean tech and research & development conclude that California has a number of problems that prevent businesses from locating or expanding in the state. The Pacific Research Institute survey discovered that housing and real ...
Joel Fox
March 6, 2018
Book
Sally Pipes Releases New Book The False Promise of Single-Payer Health Care
As the political drumbeat for single-payer health care rises in Sacramento, other states around the country, and in Washington, DC, PRI’s Sally Pipes today released a new book that makes the case for why single-payer health care would be a disaster for all Americans, The False Promise of Single-Payer Health ...
Sally C. Pipes
March 5, 2018
Health Care
Flu Rages as FDA Approval Process Delays New Cure
As one of the worst influenza outbreaks in recent history continues to spread in the United States, the release of a new drug that could quickly cure the illness is being delayed by Food & Drug Administration’s (FDA) overly cumbersome approval process. Centers for Disease Control and Prevention acting director ...
Michael McGrady
March 5, 2018
Health Care
20 Companies Already Have a Healthcare Alliance Like the Amazon, Berkshire and JP Morgan Plan — Is It Working?
By Jeri Clausing When Amazon, Berkshire Hathaway and JP Morgan announced plans earlier this month to create a new company that will take charge of healthcare delivery to their more than 1 million combined workers, it created a lot of buzz, both because of the high-profile players and the scant ...
Pacific Research Institute
February 28, 2018
Business & Economics
Economist: Leahy’s CREATES Act, Excluded From Budget, Would Help Trial Lawyers, Hurt Patients
By Glenn Minnis Despite support from a few Republicans, a measure championed by Sen. Pat Leahy, D-VT, targeting health care costs did not make its way into the budget passed by Congress earlier this month. The exclusion of the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act disappointed ...
Pacific Research Institute
February 23, 2018
California
PRI Files Amicus Brief in Closely Watched Cal Fire Case
Click here to download a copy of the brief SAN FRANCISCO – California-based non-partisan think tank Pacific Research Institute has filed an amicus brief before the California Supreme Court on a closely-watched case that challenges the ability of state and local governments to adjust future pension benefits for current workers. ...
Pacific Research Institute
February 22, 2018
Charter Schools
Here’s Why The Education Department Eliminated Its ‘Extremely Wasteful Programs,’ According To Expert
The Department of Education requested over 10 percent less funding for its 2018 budget, and an education scholar explained Friday why he supported the decision. The Trump administration requested $59.9 billion for 2018 — an amount $7.1 billion smaller than its 2017 budget. Lance Izumi, senior director of education studies ...
Rob Shimshock
February 17, 2018
Business & Economics
Report Slams 340B Drug Discount Program
By Tracey Walker The 340B Drug Discount program, designed to give discounted prescription drugs to poor Americans, has not been effective in serving its targeted population, according to a new report. The report, “Addressing the Problems of Abuse in the 340B Drug Pricing Program,” by the Pacific Research Institute, found that the ...
Pacific Research Institute
February 12, 2018
Mass Transit Ridership is Falling in Southern California, Study Finds
By Kenneth Artz A new study finds commuters are increasingly choosing to use cars over mass transit in Southern California. Mass transit use in six southern California counties declined significantly during the past decade, according to a new study by researchers at the University of California at Los Angeles (UCLA) ...
Small Business Taxes: What to Expect in 2018
By Matt D’Angelo The recent tax legislation mean small businesses everywhere are getting a break on their taxes. The legislation, which is one of the most significant tax overhauls passed in decades, provides pass-through businesses and corporate entities with lower rates. Insureon, an insurance company that works with small businesses, ...
Joel Fox on PRI’s California Business Climate Survey
Survey: Biz Execs Down on CA A survey of business executives in highly sought after industries such as clean tech and research & development conclude that California has a number of problems that prevent businesses from locating or expanding in the state. The Pacific Research Institute survey discovered that housing and real ...
Sally Pipes Releases New Book The False Promise of Single-Payer Health Care
As the political drumbeat for single-payer health care rises in Sacramento, other states around the country, and in Washington, DC, PRI’s Sally Pipes today released a new book that makes the case for why single-payer health care would be a disaster for all Americans, The False Promise of Single-Payer Health ...
Flu Rages as FDA Approval Process Delays New Cure
As one of the worst influenza outbreaks in recent history continues to spread in the United States, the release of a new drug that could quickly cure the illness is being delayed by Food & Drug Administration’s (FDA) overly cumbersome approval process. Centers for Disease Control and Prevention acting director ...
20 Companies Already Have a Healthcare Alliance Like the Amazon, Berkshire and JP Morgan Plan — Is It Working?
By Jeri Clausing When Amazon, Berkshire Hathaway and JP Morgan announced plans earlier this month to create a new company that will take charge of healthcare delivery to their more than 1 million combined workers, it created a lot of buzz, both because of the high-profile players and the scant ...
Economist: Leahy’s CREATES Act, Excluded From Budget, Would Help Trial Lawyers, Hurt Patients
By Glenn Minnis Despite support from a few Republicans, a measure championed by Sen. Pat Leahy, D-VT, targeting health care costs did not make its way into the budget passed by Congress earlier this month. The exclusion of the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act disappointed ...
PRI Files Amicus Brief in Closely Watched Cal Fire Case
Click here to download a copy of the brief SAN FRANCISCO – California-based non-partisan think tank Pacific Research Institute has filed an amicus brief before the California Supreme Court on a closely-watched case that challenges the ability of state and local governments to adjust future pension benefits for current workers. ...
Here’s Why The Education Department Eliminated Its ‘Extremely Wasteful Programs,’ According To Expert
The Department of Education requested over 10 percent less funding for its 2018 budget, and an education scholar explained Friday why he supported the decision. The Trump administration requested $59.9 billion for 2018 — an amount $7.1 billion smaller than its 2017 budget. Lance Izumi, senior director of education studies ...
Report Slams 340B Drug Discount Program
By Tracey Walker The 340B Drug Discount program, designed to give discounted prescription drugs to poor Americans, has not been effective in serving its targeted population, according to a new report. The report, “Addressing the Problems of Abuse in the 340B Drug Pricing Program,” by the Pacific Research Institute, found that the ...